At intake submission: Eligibility evaluation begins only when the questionnaire is routed for review, which Willow describes as a clinician decision point outside the platform
Logistics: What does your insurance plan actually cover, and what is your out-of-pocket budget
The terms used were: GLP-1 receptor agonists, SGLT2 inhibitors, cardiovascular, renal, benefit, outcome, empagliflozin, dapagliflozin, canagliflozin, sotagliflozin, ertugliflozin, dulaglutide, liraglutide, semaglutide, lixisenatide, exenatide, efpeglenatide, and albiglutide
Learn more: #MSFTAdvocate To view or add a comment, sign in 88,328 followers More from this author Why You Should Contact Your Congressional Representative About OMBs Proposed Changes to Federal Funding American Association for Cancer Research 1w The Power of Discovery Science and Global Collaboration American Association for Cancer Research 1mo Takeaways From the AACR Annual Meeting 2026 American Association for Cancer Research 2mo
Large-Scale Trials: In large-scale trials involving thousands of patients, semaglutide has not been shown to cause hyperthyroidism
